Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Jan 2, 2026 3:59:50 PM EST

16.56USD+6.018%(+0.94)569,537

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 2, 2026 9:27:30 AM EST

16.30USD+4.353%(+0.68)3,542

After-hours

Jan 2, 2026 4:23:30 PM EST

16.85USD+1.751%(+0.29)896

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

195.14M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Mar 16, 2026 (70d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

541,018

Avg. Vol. 30 Day

649,279

Employees

Market Cap

195,137,301

Shares Out.

11,776,542

On/Off Exchange

48%/52%

6 Month Beta

3.16

1 Year Beta

1.01

2 Year Beta

1.08

3 Year Beta

1.14

52 Week Low

6.76

52 Week High

69.97

SMA50

17.47

SMA200

27.04

1 Week

+1.78%

1 Month

-15.16%

3 Month

-30.96%

6 Month

-53.30%

1 Year

-46.55%

2 Year

-98.63%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $16.56, and today's volume is 569,537. TNXP is up 6.018% today. The 30 day average volume is 649,279. TNXP market cap is 195.14M with 11,776,542 shares outstanding.